{
    "title": "EXPLAINER-What does new data say about Gilead's experimental coronavirus drug?",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8271305/EXPLAINER-What-does-new-data-say-Gileads-experimental-coronavirus-drug.html",
    "date": "2020-04-29",
    "keywords": [
        "drug",
        "treatment",
        "trial",
        "remdesivir",
        "study",
        "covid19",
        "group",
        "placebo",
        "gilead",
        "control",
        "china",
        "nancy",
        "york",
        "analysis",
        "death",
        "versus",
        "illness",
        "course",
        "therapy",
        "hospital",
        "direction",
        "reporting",
        "april",
        "coronavirus",
        "worldwide",
        "excitement",
        "confusion",
        "circumstance",
        "impact",
        "rate",
        "following",
        "institute",
        "allergy",
        "lung",
        "faster",
        "time",
        "survival",
        "benefit",
        "difference",
        "chance",
        "effect",
        "goal",
        "promising",
        "niaid",
        "month",
        "cost",
        "improvement",
        "sooner",
        "epicenter",
        "amount",
        "virus",
        "body",
        "risk",
        "outbreak",
        "trouble",
        "report",
        "review",
        "publication",
        "lancet",
        "day",
        "lynch",
        "assistant",
        "professor",
        "university",
        "pennsylvania",
        "cant",
        "breaker",
        "julie",
        "steenhuysen",
        "chicago",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}